Shangqiu Meilan Bioengineering Co., Ltd. was established in 2013 with a total investment of 1 billion yuan, and the first-phase project investment of 350 million yuan. It covers an area of more than 120 acres and is located in the High-tech Development Zone of Zhecheng County. It has a production workshop for veterinary biological products, a quality inspection center, an experimental animal room and an office building. Meilan Bio has successively won honors such as Henan Province Pathogenic Microorganism Genetic Engineering Technology Research Center, Key Microbiology Laboratory, and Postdoctoral Research Station. The company relies on well-known domestic scientific research institutions such as Nanjing Agricultural University, Shandong Agricultural University, Henan Agricultural University, Henan Animal Husbandry Economics College, Harbin Veterinary Research Institute, etc.; actively researches and develops new products and new processes. At present, the company’s research and development capabilities have reached the domestic level.
Meilan Bio currently has 11 livestock and poultry production lines, which can produce live embryotoxic vaccine, inactivated embryonic vaccine, inactivated cytotoxic suspension culture vaccine, live swine fever vaccine (rabbit source), bacterial vaccine, egg yolk antibody and other products. The estimated annual production capacity of the Meilan biological production line: 8 billion vaccines for poultry and 1 billion vaccines for livestock. The production equipment has a high degree of automation and is currently the leader of the domestic veterinary vaccine full suspension culture process. At present, the comprehensive production capacity is at the domestic level.
Meilan Bio focuses on investment in product research and strengthens alliances, especially the research on vaccine adjuvants, which has taken the lead among peers. Meilan Bio always upholds that corporate standards are higher than standards, product positioning is high-end, and the clinical protection rate is higher than the industry average. Meilan Bio is committed to the new trend of animal husbandry biological products, escorting the healthy and orderly development of animal husbandry!
Meilan Bio is a high-tech group integrating the production and research and development of biological products, veterinary drugs, feed additives, antibodies and Herbal Medicine. Our company can produce lyophilized embryotoxin live vaccines, inactivated embryotoxin vaccines, lyophilized live vaccines by cell suspension culture, inactivated vaccines by cell suspension culture, genetically engineered vaccines, bacterial vaccines, etc. We have set up our own biological product research anddevelopment center Meilan Research Institute, introduced a research and development team composed mainly of doctors and masters and built first-rate infrastructure and experiment conditions, a top-notch animal experiment base and supporting facilities.
We have built partnerships with domestic well-known scientific research institutes and universities such as Nanjing Agricultural University, Shandong Agricultural University, Henan Agricultural University, Henan University of Animal Husbandry and Economy, China Agricultural University, Chinese Academy of Sciences and Harbin Veterinary Research Institute, and interacted with Cornell University College of Veterinary Medicine and Veterinary Medicine College of Leibniz University Hannover. We have founded a postdoctoral scientific research center and an innovation and practice base and set up first-rate scientific research platforms which are the Enterprise Technology Center of Henan, the Henan Technological Research Center of Pathogenic Microorganism Gene Engineering, the Pilot Cooperation Project of Enterprises, Universities and Research Institutes in Henan, the Veterinary Preparation Engineering Research Center of Henan, the New Veterinary Traditional Chinese Medicine Preparation Engineering Test Center of Henan and the New Veterinary Traditional Chinese Medicine Preparation Engineering Laboratory of Henan. We tackled global problems in the field of cell suspension culture technology.
Our company was the first one producing animal vaccines by cell suspension culture technology and ended the technical limitation that production of vaccines depends on SPF eggs. Therefore, we guarantee purer and more stable vaccines with a higher antibody titerand better immune effects. Now we are looking for agents and distributors all over the world.
